BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Engel JA, Jerlhag E. Role of appetite-regulating peptides in the pathophysiology of addiction: implications for pharmacotherapy. CNS Drugs 2014;28:875-86. [PMID: 24958205 DOI: 10.1007/s40263-014-0178-y] [Cited by in Crossref: 73] [Cited by in F6Publishing: 68] [Article Influence: 10.4] [Reference Citation Analysis]
Number Citing Articles
1 Vallöf D, Vestlund J, Engel JA, Jerlhag E. The Anorexigenic Peptide Neuromedin U (NMU) Attenuates Amphetamine-Induced Locomotor Stimulation, Accumbal Dopamine Release and Expression of Conditioned Place Preference in Mice. PLoS One 2016;11:e0154477. [PMID: 27139195 DOI: 10.1371/journal.pone.0154477] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
2 Engel JA, Nylander I, Jerlhag E. A ghrelin receptor (GHS-R1A) antagonist attenuates the rewarding properties of morphine and increases opioid peptide levels in reward areas in mice. European Neuropsychopharmacology 2015;25:2364-71. [DOI: 10.1016/j.euroneuro.2015.10.004] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
3 Gupta S, Mukhopadhyay S, Mitra A. Therapeutic potential of GHSR-1A antagonism in alcohol dependence, a review. Life Sci 2022;291:120316. [PMID: 35016882 DOI: 10.1016/j.lfs.2022.120316] [Reference Citation Analysis]
4 Hoffman PL, Saba LM, Vanderlinden LA, Tabakoff B. Voluntary exposure to a toxin: the genetic influence on ethanol consumption. Mamm Genome 2018;29:128-40. [PMID: 29196862 DOI: 10.1007/s00335-017-9726-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
5 Patel S. Cereal bran fortified-functional foods for obesity and diabetes management: Triumphs, hurdles and possibilities. Journal of Functional Foods 2015;14:255-69. [DOI: 10.1016/j.jff.2015.02.010] [Cited by in Crossref: 51] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
6 Schmidt HD, Rupprecht LE, Addy NA. Neurobiological and Neurophysiological Mechanisms Underlying Nicotine Seeking and Smoking Relapse. Mol Neuropsychiatry 2019;4:169-89. [PMID: 30815453 DOI: 10.1159/000494799] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
7 Herrington JA, Guss Darwich J, Harshaw C, Brigande AM, Leif EB, Currie PJ. Elevated ghrelin alters the behavioral effects of perinatal acetaminophen exposure in rats. Developmental Psychobiology 2022;64. [DOI: 10.1002/dev.22252] [Reference Citation Analysis]
8 Hou Y, Wu Z, Dai Z, Wang G, Wu G. Protein hydrolysates in animal nutrition: Industrial production, bioactive peptides, and functional significance. J Anim Sci Biotechnol 2017;8:24. [PMID: 28286649 DOI: 10.1186/s40104-017-0153-9] [Cited by in Crossref: 111] [Cited by in F6Publishing: 63] [Article Influence: 22.2] [Reference Citation Analysis]
9 Bouhlal S, Ellefsen KN, Sheskier MB, Singley E, Pirard S, Gorelick DA, Huestis MA, Leggio L. Acute effects of intravenous cocaine administration on serum concentrations of ghrelin, amylin, glucagon-like peptide-1, insulin, leptin and peptide YY and relationships with cardiorespiratory and subjective responses. Drug Alcohol Depend 2017;180:68-75. [PMID: 28881319 DOI: 10.1016/j.drugalcdep.2017.07.033] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
10 Szakács J, Csabafi K, Lipták N, Szabó G. The effect of obestatin on anxiety-like behaviour in mice. Behavioural Brain Research 2015;293:41-5. [DOI: 10.1016/j.bbr.2015.06.042] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
11 Xiao X, Qin M, Zhang F, Su Y, Zhou B, Zhou Z. Understanding the Mechanism of Activation/Deactivation of GLP-1R via Accelerated Molecular Dynamics Simulation. Aust J Chem 2021;74:211. [DOI: 10.1071/ch20127] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Reichelt AC, Westbrook RF, Morris MJ. Integration of reward signalling and appetite regulating peptide systems in the control of food-cue responses. Br J Pharmacol 2015;172:5225-38. [PMID: 26403657 DOI: 10.1111/bph.13321] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
13 Egecioglu E, Prieto-Garcia L, Studer E, Westberg L, Jerlhag E. The role of ghrelin signalling for sexual behaviour in male mice. Addict Biol 2016;21:348-59. [PMID: 25475101 DOI: 10.1111/adb.12202] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
14 Colon-perez L, Montesinos J, Monsivais M. The Future of Neuroimaging and Gut-Brain Axis Research for Substance Use Disorders. Brain Research 2022. [DOI: 10.1016/j.brainres.2022.147835] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Kalafateli AL, Vallöf D, Jerlhag E. Activation of amylin receptors attenuates alcohol-mediated behaviours in rodents. Addict Biol 2019;24:388-402. [PMID: 29405517 DOI: 10.1111/adb.12603] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
16 Jensen ME, Galli A, Thomsen M, Jensen KL, Thomsen GK, Klausen MK, Vilsbøll T, Christensen MB, Holst JJ, Owens A, Robertson S, Daws L, Zanella D, Gether U, Knudsen GM, Fink-Jensen A. Glucagon-like peptide-1 receptor regulation of basal dopamine transporter activity is species-dependent. Neurochem Int 2020;138:104772. [PMID: 32464226 DOI: 10.1016/j.neuint.2020.104772] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
17 Blackburn AN, Hajnal A, Leggio L. The gut in the brain: the effects of bariatric surgery on alcohol consumption. Addict Biol 2017;22:1540-53. [PMID: 27578259 DOI: 10.1111/adb.12436] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 8.4] [Reference Citation Analysis]
18 Vallöf D, Ulenius L, Egecioglu E, Engel JA, Jerlhag E. Central administration of the anorexigenic peptide neuromedin U decreases alcohol intake and attenuates alcohol-induced reward in rodents. Addict Biol 2017;22:640-51. [PMID: 26769653 DOI: 10.1111/adb.12355] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
19 Yammine L, Kosten TR, Cinciripini PM, Green CE, Meininger JC, Minnix JA, Newton TF. Exenatide once weekly for smoking cessation: study protocol for a randomized clinical trial. Medicine (Baltimore) 2018;97:e9567. [PMID: 29480848 DOI: 10.1097/MD.0000000000009567] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
20 Deschaine SL, Farokhnia M, Gregory-Flores A, Zallar LJ, You ZB, Sun H, Harvey DM, Marchette RCN, Tunstall BJ, Mani BK, Moose JE, Lee MR, Gardner E, Akhlaghi F, Roberto M, Hougland JL, Zigman JM, Koob GF, Vendruscolo LF, Leggio L. A closer look at alcohol-induced changes in the ghrelin system: novel insights from preclinical and clinical data. Addict Biol 2022;27:e13033. [PMID: 33908131 DOI: 10.1111/adb.13033] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
21 Sethi Dalai S, Sinha A, Gearhardt AN. Low carbohydrate ketogenic therapy as a metabolic treatment for binge eating and ultraprocessed food addiction. Curr Opin Endocrinol Diabetes Obes 2020;27:275-82. [PMID: 32773576 DOI: 10.1097/MED.0000000000000571] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 11.0] [Reference Citation Analysis]
22 Volkow ND, Wise RA, Baler R. The dopamine motive system: implications for drug and food addiction. Nat Rev Neurosci 2017;18:741-52. [DOI: 10.1038/nrn.2017.130] [Cited by in Crossref: 332] [Cited by in F6Publishing: 281] [Article Influence: 66.4] [Reference Citation Analysis]
23 Vestlund J, Winsa-jörnulf J, Hovey D, Lundström S, Lichtenstein P, Anckarsäter H, Studer E, Suchankova P, Westberg L, Jerlhag E. Ghrelin and aggressive behaviours—Evidence from preclinical and human genetic studies. Psychoneuroendocrinology 2019;104:80-8. [DOI: 10.1016/j.psyneuen.2019.02.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
24 Hayes MR, Schmidt HD. GLP-1 influences food and drug reward. Curr Opin Behav Sci 2016;9:66-70. [PMID: 27066524 DOI: 10.1016/j.cobeha.2016.02.005] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 7.8] [Reference Citation Analysis]
25 Sustkova-Fiserova M, Puskina N, Havlickova T, Lapka M, Syslova K, Pohorala V, Charalambous C. Ghrelin receptor antagonism of fentanyl-induced conditioned place preference, intravenous self-administration, and dopamine release in the nucleus accumbens in rats. Addict Biol 2020;25:e12845. [PMID: 31696597 DOI: 10.1111/adb.12845] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
26 Jerlhag E. GLP-1 signaling and alcohol-mediated behaviors; preclinical and clinical evidence. Neuropharmacology 2018;136:343-9. [PMID: 29337226 DOI: 10.1016/j.neuropharm.2018.01.013] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
27 Verdejo-Garcia A, Crossin R. Nutritional and metabolic alterations arising from stimulant use: A targeted review of an emerging field. Neurosci Biobehav Rev 2021;120:303-6. [PMID: 33188822 DOI: 10.1016/j.neubiorev.2020.11.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
28 Zhu C, Li H, Kong X, Wang Y, Sun T, Wang F. Possible Mechanisms Underlying the Effects of Glucagon-Like Peptide-1 Receptor Agonist on Cocaine Use Disorder. Front Pharmacol 2022;13:819470. [PMID: 35300299 DOI: 10.3389/fphar.2022.819470] [Reference Citation Analysis]
29 Haass-Koffler CL, Giovenco DE, Lee MR, Zywiak WH, de la Monte SM, Kenna GA, Swift RM, Leggio L. Serum Insulin Levels Are Reduced by Intravenous Ghrelin Administration but Do Not Correlate with Alcohol Craving in Alcohol-Dependent Individuals. Int J Neuropsychopharmacol 2016;19:pyw048. [PMID: 27207912 DOI: 10.1093/ijnp/pyw048] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
30 Havlickova T, Charalambous C, Lapka M, Puskina N, Jerabek P, Sustkova-Fiserova M. Ghrelin Receptor Antagonism of Methamphetamine-Induced Conditioned Place Preference and Intravenous Self-Administration in Rats. Int J Mol Sci 2018;19:E2925. [PMID: 30261633 DOI: 10.3390/ijms19102925] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
31 Kurt Tunagur EM, Yazici AB, Guzel D, Tunagur MT, Ermis C, Suda MA, Yazici E. Investigating associations between appetite-regulating hormones, aggression and craving in males with cannabis use disorder. Drug Alcohol Depend 2022;238:109577. [PMID: 35905593 DOI: 10.1016/j.drugalcdep.2022.109577] [Reference Citation Analysis]
32 Stärkel P, Leclercq S, Delzenne N, de Timary P. Alcohol-Dependence and the Microbiota-Gut-Brain Axis. The Gut-Brain Axis. Elsevier; 2016. pp. 363-90. [DOI: 10.1016/b978-0-12-802304-4.00017-7] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
33 Farokhnia M, Abshire KM, Hammer A, Deschaine SL, Saravanakumar A, Cobbina E, You ZB, Haass-Koffler CL, Lee MR, Akhlaghi F, Leggio L. Neuroendocrine Response to Exogenous Ghrelin Administration, Combined With Alcohol, in Heavy-Drinking Individuals: Findings From a Randomized, Double-Blind, Placebo-Controlled Human Laboratory Study. Int J Neuropsychopharmacol 2021;24:464-76. [PMID: 33560411 DOI: 10.1093/ijnp/pyab004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
34 de Timary P, Leclercq S, Stärkel P, Delzenne N. A dysbiotic subpopulation of alcohol-dependent subjects. Gut Microbes 2015;6:388-91. [PMID: 26727422 DOI: 10.1080/19490976.2015.1107696] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
35 Mahajan VR, Elvig SK, Vendruscolo LF, Koob GF, Darcey VL, King MT, Kranzler HR, Volkow ND, Wiers CE. Nutritional Ketosis as a Potential Treatment for Alcohol Use Disorder. Front Psychiatry 2021;12:781668. [PMID: 34916977 DOI: 10.3389/fpsyt.2021.781668] [Reference Citation Analysis]
36 Pankova A, Kralikova E, Kavalkova P, Stepankova L, Zvolska K, Haluzik M. No Change in Serum Incretins Levels but Rise of Leptin Levels After Smoking Cessation: a Pilot Study. Physiol Res. [DOI: 10.33549/physiolres.933154] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
37 Tichonenko EV, Tsoi UA, Vasilieva EY, Babenko AY. Characteristics of eating behavior and the level of hormones regulating the appetite in patients with type 2 diabetes mellitus and body mass index more than 35 kg /m2. Obes metabol 2018;15:30-8. [DOI: 10.14341/omet2018130-38] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
38 McCreary AC, Müller CP, Filip M. Psychostimulants: Basic and Clinical Pharmacology. Int Rev Neurobiol 2015;120:41-83. [PMID: 26070753 DOI: 10.1016/bs.irn.2015.02.008] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
39 Michaelides M, Miller ML, DiNieri JA, Gomez JL, Schwartz E, Egervari G, Wang GJ, Mobbs CV, Volkow ND, Hurd YL. Dopamine D2 Receptor Signaling in the Nucleus Accumbens Comprises a Metabolic-Cognitive Brain Interface Regulating Metabolic Components of Glucose Reinforcement. Neuropsychopharmacology 2017;42:2365-76. [PMID: 28580946 DOI: 10.1038/npp.2017.112] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
40 Farokhnia M, Sheskier MB, Lee MR, Le AN, Singley E, Bouhlal S, Ton T, Zhao Z, Leggio L. Neuroendocrine response to GABA-B receptor agonism in alcohol-dependent individuals: Results from a combined outpatient and human laboratory experiment. Neuropharmacology 2018;137:230-9. [PMID: 29665351 DOI: 10.1016/j.neuropharm.2018.04.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
41 Winzeler B, Sailer CO, Coynel D, Zanchi D, Vogt DR, Urwyler SA, Refardt J, Christ-Crain M. A randomized controlled trial of the GLP-1 receptor agonist dulaglutide in primary polydipsia. J Clin Invest 2021;131:e151800. [PMID: 34473645 DOI: 10.1172/JCI151800] [Reference Citation Analysis]
42 Jerabek P, Havlickova T, Puskina N, Charalambous C, Lapka M, Kacer P, Sustkova-fiserova M. Ghrelin receptor antagonism of morphine-induced conditioned place preference and behavioral and accumbens dopaminergic sensitization in rats. Neurochemistry International 2017;110:101-13. [DOI: 10.1016/j.neuint.2017.09.013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
43 Calderón-Garcidueñas L, Franco-Lira M, D'Angiulli A, Rodríguez-Díaz J, Blaurock-Busch E, Busch Y, Chao CK, Thompson C, Mukherjee PS, Torres-Jardón R, Perry G. Mexico City normal weight children exposed to high concentrations of ambient PM2.5 show high blood leptin and endothelin-1, vitamin D deficiency, and food reward hormone dysregulation versus low pollution controls. Relevance for obesity and Alzheimer disease. Environ Res 2015;140:579-92. [PMID: 26037109 DOI: 10.1016/j.envres.2015.05.012] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 7.1] [Reference Citation Analysis]
44 Winzeler B, da Conceição I, Refardt J, Sailer CO, Dutilh G, Christ-Crain M. Effects of glucagon-like peptide-1 receptor agonists on fluid intake in healthy volunteers. Endocrine 2020;70:292-8. [PMID: 32623637 DOI: 10.1007/s12020-020-02394-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
45 Haass-Koffler CL, Long VM, Farokhnia M, Magill M, Kenna GA, Swift RM, Leggio L. Intravenous administration of ghrelin increases serum cortisol and aldosterone concentrations in heavy-drinking alcohol-dependent individuals: Results from a double-blind, placebo-controlled human laboratory study. Neuropharmacology 2019;158:107711. [PMID: 31310775 DOI: 10.1016/j.neuropharm.2019.107711] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
46 Hennink MM, Kaiser BN, Marconi VC. Pathways to Retention in HIV Care Among U.S. Veterans. AIDS Res Hum Retroviruses 2018;34:517-26. [PMID: 29490468 DOI: 10.1089/AID.2017.0201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
47 Buyuktuncer Z, Akyol A, Ayaz A, Nergiz-Unal R, Aksoy B, Cosgun E, Ozdemir P, Pekcan G, Besler HT. Turkish version of the Yale Food Addiction Scale: preliminary results of factorial structure, reliability, and construct validity. J Health Popul Nutr 2019;38:42. [PMID: 31822299 DOI: 10.1186/s41043-019-0202-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
48 Ren M, Lotfipour S. The role of the gut microbiome in opioid use. Behav Pharmacol 2020;31:113-21. [PMID: 31895059 DOI: 10.1097/FBP.0000000000000538] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 6.5] [Reference Citation Analysis]
49 Webber KH, Casey EM, Mayes L, Katsumata Y, Mellin L. A comparison of a behavioral weight loss program to a stress management program: A pilot randomized controlled trial. Nutrition 2016;32:904-9. [PMID: 27138110 DOI: 10.1016/j.nut.2016.01.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
50 Chao AM, Wadden TA, Ashare RL, Loughead J, Schmidt HD. Tobacco Smoking, Eating Behaviors, and Body Weight: A Review. Curr Addict Rep 2019;6:191-9. [PMID: 33224710 DOI: 10.1007/s40429-019-00253-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
51 Zhu C, Hong T, Li H, Jiang S, Guo B, Wang L, Ding J, Gao C, Sun Y, Sun T, Wang F, Wang Y, Wan D. Glucagon-Like Peptide-1 Agonist Exendin-4 Facilitates the Extinction of Cocaine-Induced Condition Place Preference. Front Syst Neurosci 2021;15:711750. [PMID: 35024034 DOI: 10.3389/fnsys.2021.711750] [Reference Citation Analysis]
52 Demirel G, Guzel E, Creighton CJ, Ozturk YE, Kucuk C, Asliyuksek H, Yurdun T. MDMA Abuse in Relation to MicroRNA Variation in Human Brain Ventral Tegmental Area and Nucleus Accumbens. Iran J Pharm Res 2019;18:1989-99. [PMID: 32184864 DOI: 10.22037/ijpr.2019.15097.12874] [Reference Citation Analysis]
53 Schmidt HD, Mietlicki-Baase EG, Ige KY, Maurer JJ, Reiner DJ, Zimmer DJ, Van Nest DS, Guercio LA, Wimmer ME, Olivos DR, De Jonghe BC, Hayes MR. Glucagon-Like Peptide-1 Receptor Activation in the Ventral Tegmental Area Decreases the Reinforcing Efficacy of Cocaine. Neuropsychopharmacology 2016;41:1917-28. [PMID: 26675243 DOI: 10.1038/npp.2015.362] [Cited by in Crossref: 76] [Cited by in F6Publishing: 73] [Article Influence: 10.9] [Reference Citation Analysis]
54 Fortin SM, Roitman MF. Central GLP-1 receptor activation modulates cocaine-evoked phasic dopamine signaling in the nucleus accumbens core. Physiol Behav 2017;176:17-25. [PMID: 28315693 DOI: 10.1016/j.physbeh.2017.03.019] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 6.6] [Reference Citation Analysis]
55 Kalafateli AL, Vallöf D, Jörnulf JW, Heilig M, Jerlhag E. A cannabinoid receptor antagonist attenuates ghrelin-induced activation of the mesolimbic dopamine system in mice. Physiol Behav 2018;184:211-9. [PMID: 29221808 DOI: 10.1016/j.physbeh.2017.12.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
56 Bouhlal S, Farokhnia M, Lee MR, Akhlaghi F, Leggio L. Identifying and Characterizing Subpopulations of Heavy Alcohol Drinkers Via a Sucrose Preference Test: A Sweet Road to a Better Phenotypic Characterization? Alcohol Alcohol 2018;53:560-9. [PMID: 30016385 DOI: 10.1093/alcalc/agy048] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
57 Farokhnia M, McDiarmid GR, Newmeyer MN, Munjal V, Abulseoud OA, Huestis MA, Leggio L. Effects of oral, smoked, and vaporized cannabis on endocrine pathways related to appetite and metabolism: a randomized, double-blind, placebo-controlled, human laboratory study. Transl Psychiatry 2020;10:71. [PMID: 32075958 DOI: 10.1038/s41398-020-0756-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 13.0] [Reference Citation Analysis]
58 Haass-Koffler CL, Aoun EG, Swift RM, de la Monte SM, Kenna GA, Leggio L. Leptin levels are reduced by intravenous ghrelin administration and correlated with cue-induced alcohol craving. Transl Psychiatry 2015;5:e646. [PMID: 26418274 DOI: 10.1038/tp.2015.140] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.6] [Reference Citation Analysis]
59 Sustkova-Fiserova M, Charalambous C, Khryakova A, Certilina A, Lapka M, Šlamberová R. The Role of Ghrelin/GHS-R1A Signaling in Nonalcohol Drug Addictions. Int J Mol Sci 2022;23:761. [PMID: 35054944 DOI: 10.3390/ijms23020761] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
60 Vallöf D, Maccioni P, Colombo G, Mandrapa M, Jörnulf JW, Egecioglu E, Engel JA, Jerlhag E. The glucagon-like peptide 1 receptor agonist liraglutide attenuates the reinforcing properties of alcohol in rodents. Addict Biol 2016;21:422-37. [PMID: 26303264 DOI: 10.1111/adb.12295] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 7.2] [Reference Citation Analysis]
61 Lemieux AM, al'Absi M. Changes in circulating peptide YY and ghrelin are associated with early smoking relapse. Biol Psychol 2018;131:43-8. [PMID: 28300626 DOI: 10.1016/j.biopsycho.2017.03.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
62 Kahl KG, Hillemacher T. The metabolic syndrome in patients with alcohol dependency: Current research and clinical implications. Prog Neuropsychopharmacol Biol Psychiatry 2016;70:49-56. [PMID: 27174541 DOI: 10.1016/j.pnpbp.2016.05.001] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
63 Zhang X, Melrose AJ, De Santis O, Luo S, Page KA, Hsu E, Monterosso JR. Fasting may increase incentive signaling for nonfood rewards. Nutr Res 2020;77:43-53. [PMID: 32315894 DOI: 10.1016/j.nutres.2020.02.013] [Reference Citation Analysis]
64 Thomsen M, Dencker D, Wörtwein G, Weikop P, Egecioglu E, Jerlhag E, Fink-Jensen A, Molander A. The glucagon-like peptide 1 receptor agonist Exendin-4 decreases relapse-like drinking in socially housed mice. Pharmacol Biochem Behav 2017;160:14-20. [PMID: 28778739 DOI: 10.1016/j.pbb.2017.07.014] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 6.6] [Reference Citation Analysis]
65 Charalambous C, Havlickova T, Lapka M, Puskina N, Šlamberová R, Kuchar M, Sustkova-Fiserova M. Cannabinoid-Induced Conditioned Place Preference, Intravenous Self-Administration, and Behavioral Stimulation Influenced by Ghrelin Receptor Antagonism in Rats. Int J Mol Sci 2021;22:2397. [PMID: 33673659 DOI: 10.3390/ijms22052397] [Reference Citation Analysis]
66 Kalafateli AL, Vallöf D, Colombo G, Lorrai I, Maccioni P, Jerlhag E. An amylin analogue attenuates alcohol-related behaviours in various animal models of alcohol use disorder. Neuropsychopharmacology 2019;44:1093-102. [PMID: 30710109 DOI: 10.1038/s41386-019-0323-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
67 Schneider R Jr, Santos CF, Clarimundo V, Dalmaz C, Elisabetsky E, Gomez R. N-acetylcysteine prevents behavioral and biochemical changes induced by alcohol cessation in rats. Alcohol 2015;49:259-63. [PMID: 25771148 DOI: 10.1016/j.alcohol.2015.01.009] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
68 Hu T, Yang Z, Li MD. Pharmacological Effects and Regulatory Mechanisms of Tobacco Smoking Effects on Food Intake and Weight Control. J Neuroimmune Pharmacol 2018;13:453-66. [PMID: 30054897 DOI: 10.1007/s11481-018-9800-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
69 Suchankova P, Engel JA, Jerlhag E. Sub-chronic Ghrelin Receptor Blockade Attenuates Alcohol- and Amphetamine-Induced Locomotor Stimulation in Mice. Alcohol and Alcoholism 2016;51:121-7. [DOI: 10.1093/alcalc/agv100] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
70 Temko JE, Bouhlal S, Farokhnia M, Lee MR, Cryan JF, Leggio L. The Microbiota, the Gut and the Brain in Eating and Alcohol Use Disorders: A 'Ménage à Trois'? Alcohol Alcohol 2017;52:403-13. [PMID: 28482009 DOI: 10.1093/alcalc/agx024] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 9.0] [Reference Citation Analysis]
71 Hernandez NS, Schmidt HD. Central GLP-1 receptors: Novel molecular targets for cocaine use disorder. Physiol Behav 2019;206:93-105. [PMID: 30930091 DOI: 10.1016/j.physbeh.2019.03.026] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
72 Hernandez NS, Ige KY, Mietlicki-Baase EG, Molina-Castro GC, Turner CA, Hayes MR, Schmidt HD. Glucagon-like peptide-1 receptor activation in the ventral tegmental area attenuates cocaine seeking in rats. Neuropsychopharmacology 2018;43:2000-8. [PMID: 29497166 DOI: 10.1038/s41386-018-0010-3] [Cited by in Crossref: 57] [Cited by in F6Publishing: 49] [Article Influence: 14.3] [Reference Citation Analysis]
73 Yawalkar R, Changotra H, Gupta GL. Protective influences of N-acetylcysteine against alcohol abstinence-induced depression by regulating biochemical and GRIN2A, GRIN2B gene expression of NMDA receptor signaling pathway in rats. Neurochemistry International 2018;118:73-81. [DOI: 10.1016/j.neuint.2018.04.011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
74 Sustkova-Fiserova M, Charalambous C, Havlickova T, Lapka M, Jerabek P, Puskina N, Syslova K. Alterations in Rat Accumbens Endocannabinoid and GABA Content during Fentanyl Treatment: The Role of Ghrelin. Int J Mol Sci 2017;18:E2486. [PMID: 29165386 DOI: 10.3390/ijms18112486] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
75 Hernandez NS, O'Donovan B, Ortinski PI, Schmidt HD. Activation of glucagon-like peptide-1 receptors in the nucleus accumbens attenuates cocaine seeking in rats. Addict Biol 2019;24:170-81. [PMID: 29226617 DOI: 10.1111/adb.12583] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 12.7] [Reference Citation Analysis]
76 Goodyear K, Lee MR, Schwandt ML, Hodgkinson CA, Leggio L. Hepatic, lipid and genetic factors associated with obesity: crosstalk with alcohol dependence? World J Biol Psychiatry 2017;18:120-8. [PMID: 27905213 DOI: 10.1080/15622975.2016.1249952] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
77 Zhu C, Tao H, Rong S, Xiao L, Li X, Jiang S, Guo B, Wang L, Ding J, Gao C, Chang H, Sun T, Wang F. Glucagon-Like Peptide-1 Analog Exendin-4 Ameliorates Cocaine-Mediated Behavior by Inhibiting Toll-Like Receptor 4 Signaling in Mice. Front Pharmacol 2021;12:694476. [PMID: 34349653 DOI: 10.3389/fphar.2021.694476] [Reference Citation Analysis]
78 Shevchouk OT, Tufvesson-Alm M, Jerlhag E. An Overview of Appetite-Regulatory Peptides in Addiction Processes; From Bench to Bed Side. Front Neurosci 2021;15:774050. [PMID: 34955726 DOI: 10.3389/fnins.2021.774050] [Reference Citation Analysis]
79 Szulc M, Kujawski R, Baraniak J, Kania-Dobrowolska M, Kamińska E, Gryszczyńska A, Czora-Poczwardowska K, Winiarska H, Mikołajczak PŁ. Differential Influence of Pueraria lobata Root Extract and Its Main Isoflavones on Ghrelin Levels in Alcohol-Treated Rats. Pharmaceuticals (Basel) 2021;15:25. [PMID: 35056082 DOI: 10.3390/ph15010025] [Reference Citation Analysis]
80 Farokhnia M, Faulkner ML, Piacentino D, Lee MR, Leggio L. Ghrelin: From a gut hormone to a potential therapeutic target for alcohol use disorder. Physiology & Behavior 2019;204:49-57. [DOI: 10.1016/j.physbeh.2019.02.008] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 11.7] [Reference Citation Analysis]
81 Douton JE, Augusto C, Stoltzfus B, Carkaci-Salli N, Vrana KE, Grigson PS. Glucagon-like peptide-1 receptor agonist, exendin-4, reduces reinstatement of heroin-seeking behavior in rats. Behav Pharmacol 2021;32:265-77. [PMID: 33229892 DOI: 10.1097/FBP.0000000000000609] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 Zhu C, Wang L, Ding J, Li H, Wan D, Sun Y, Guo B, He Z, Ren X, Jiang S, Gao C, Guo H, Sun T, Wang F. Effects of Glucagon-Like Peptide-1 Receptor Agonist Exendin-4 on the Reinstatement of Cocaine-Mediated Conditioned Place Preference in Mice. Front Behav Neurosci 2022;15:769664. [DOI: 10.3389/fnbeh.2021.769664] [Reference Citation Analysis]
83 Lennerz B, Lennerz JK. Food Addiction, High-Glycemic-Index Carbohydrates, and Obesity. Clin Chem 2018;64:64-71. [PMID: 29158252 DOI: 10.1373/clinchem.2017.273532] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 8.2] [Reference Citation Analysis]